Skip to main content
Journal cover image

Telemedicine-delivered cognitive-behavioral therapy for insomnia in alcohol use disorder (AUD): study protocol for a randomized controlled trial.

Publication ,  Journal Article
Arnedt, JT; Cardoni, ME; Conroy, DA; Graham, M; Amin, S; Bohnert, KM; Krystal, AD; Ilgen, MA
Published in: Trials
January 20, 2022

BACKGROUND: Alcohol use disorder (AUD) is a leading preventable cause of morbidity and mortality, but relapse rates are high even with available treatments. Insomnia is a robust predictor of relapse and pilot studies have shown that CBT for insomnia improves insomnia and daytime functioning in adults with AUD and insomnia. The impact of CBT for insomnia on relapse, however, is unclear. This trial will compare telemedicine-delivered CBT for insomnia (CBT-TM) with sleep hygiene education (SHE-TM) on improving insomnia/sleep, daytime symptom, and drinking outcomes in treatment-seeking AUD adults with insomnia. The study will also determine the effects of treatment on sleep mechanisms and their association with clinical outcomes. METHODS: This is a single-site randomized controlled trial with planned enrollment of 150 adults meeting criteria for both AUD and chronic insomnia. Eligible participants will be randomized 1:1 to 6 sessions of telemedicine-delivered Cognitive Behavioral Therapy for Insomnia (CBT-TM) or Sleep Hygiene Education (SHE-TM) with clinical assessments conducted at pre-treatment, post- treatment, and at 3, 6, and 12 months post-treatment. Overnight polysomnography will be conducted before and after treatment. Primary clinical outcomes will include post-treatment scores on the Insomnia Severity Index and the General Fatigue subscale of the Multidisciplinary Fatigue Inventory, and the percent of days abstinent (PDA) on the interview-administered Time Line Follow Back. EEG delta activity, derived from overnight polysomnography, will be the primary endpoint to assess the sleep homeostasis mechanism. DISCUSSION: This adequately powered randomized controlled trial will provide clinically relevant information about whether targeting insomnia is effective for improving treatment outcomes among treatment-seeking adults with AUD. Additionally, the study will offer new scientific insights on the impact of an evidence-based non-medication treatment for insomnia on a candidate mechanism of sleep dysfunction in this population - sleep homeostasis. TRIAL REGISTRATION: CClinicalTrials.gov NCT # 04457674 . Registered on 07 July 2020.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Trials

DOI

EISSN

1745-6215

Publication Date

January 20, 2022

Volume

23

Issue

1

Start / End Page

59

Location

England

Related Subject Headings

  • Telemedicine
  • Sleep Initiation and Maintenance Disorders
  • Sleep
  • Randomized Controlled Trials as Topic
  • Humans
  • General & Internal Medicine
  • Cognitive Behavioral Therapy
  • Cardiovascular System & Hematology
  • Alcoholism
  • Adult
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Arnedt, J. T., Cardoni, M. E., Conroy, D. A., Graham, M., Amin, S., Bohnert, K. M., … Ilgen, M. A. (2022). Telemedicine-delivered cognitive-behavioral therapy for insomnia in alcohol use disorder (AUD): study protocol for a randomized controlled trial. Trials, 23(1), 59. https://doi.org/10.1186/s13063-021-05898-y
Journal cover image

Published In

Trials

DOI

EISSN

1745-6215

Publication Date

January 20, 2022

Volume

23

Issue

1

Start / End Page

59

Location

England

Related Subject Headings

  • Telemedicine
  • Sleep Initiation and Maintenance Disorders
  • Sleep
  • Randomized Controlled Trials as Topic
  • Humans
  • General & Internal Medicine
  • Cognitive Behavioral Therapy
  • Cardiovascular System & Hematology
  • Alcoholism
  • Adult